Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Research

Independent equity research and analysis from our analyst team

​
Company search
WindowMaster: 2026 guidance points to back on track
Research15 hours ago by
Michael Friis, Philip Coombes

WindowMaster: 2026 guidance points to back on track

In connection with yesterday’s adjustments to the 2025 guidance, WindowMaster has also provided guidance for 2026. The update points to a clear inflection in profitability, supported by improving order momentum and strong operational gearing.

WindowMaster International
Optomed: Emissionen är klar och tillväxt väntar
Research23 hours ago by
Juha Kinnunen

Optomed: Emissionen är klar och tillväxt väntar

Optomeds riktade nyemission gjordes enligt vår mening under verkligt värde, men de 6 MEUR som samlades in behövdes särskilt för Lumos FDA-process tillsammans med AI. Vi anser att utsikterna i stort sett är oförändrade och vi har endast gjort små ändringar i våra estimat för de kommande åren. Vi anser att företagets värdering är mycket måttlig i förhållande till potentialen, vilket gör risk/reward-förhållandet attraktivt.

Optomed
Digital Workforce omfattande analys: Strategiska pusselbitar på plats och nu är det dags att leverera resultat
Extensive researchyesterday by
Joni Grönqvist

Digital Workforce omfattande analys: Strategiska pusselbitar på plats och nu är det dags att leverera resultat

Under de senaste åren har strategin fokuserat på lämpligt valda branscher, utvalda tillväxtmarknader och den egna plattformen. Strategin är tilltalande, men kräver fortfarande bevis på ett genombrott. Nu måste företaget visa en återgång till bättre organisk tillväxt och dess skalbarhet till marginal.

Digital Workforce

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Bioretec: Earnings turnaround is slipping further away
Research19 hours ago by
Antti Siltanen

Bioretec: Earnings turnaround is slipping further away

Bioretec updated its strategy and financial targets for 2026-28.

Bioretec
Remedy: Forecast model updates
Research21 hours ago by
Atte Riikola

Remedy: Forecast model updates

We have corrected assumptions in our forecast model regarding Control Resonant's assumed revenue sharing ratio with Annapurna for 2027-2028.

Remedy Entertainment
Flügger Q2'2025/26 - Profitable rebound intact despite export market restructuring
Research12/15/2025, 7:25 AM by
Philip Coombes

Flügger Q2'2025/26 - Profitable rebound intact despite export market restructuring

Flügger delivered 2.2% revenue growth in H1 2025/26 to MDKK 1,264, as strong growth in Poland (International segment (12% y/y) and Sweden (+8% y/y) offset revenue declines in Denmark and other export nations. In the Nordics, a conversion of white-label volumes to own-brand sales in Denmark lifted margins; however, Group EBIT was stable at MDKK 141 (from MDKK 140 H1 2024/25), as terminated sales to nations in Eastern Europe and other non-core export markets had a negative impact on the International segment’s EBIT result year-over-year. Despite weaker EBIT expansion than projected in H1 2025/26 the structural value drivers of margin expansion in the Nordics from improved product mix and strong, higher margin growth in Poland remain unchanged. We still see a favourable risk-reward as Flügger executes its profitable rebound, despite possible sanctions-related risks, and reiterate our “Accumulate” recommendation and slightly lower price target of DKK 360 per share.

Flügger Group
Aktia extensive report: Asset Management determines success of strategy period
Extensive researchyesterday by
Kasper Mellas

Aktia extensive report: Asset Management determines success of strategy period

Aktia's earnings have risen significantly with interest rates, and the recovery in loan demand and steady growth in Asset Management should keep profitability relatively stable in the coming years.

Aktia Pankki
Panostaja: En obehaglig överraskning uppdagades i Hygga
Research12/15/2025, 6:19 AM by
Olli Vilppo

Panostaja: En obehaglig överraskning uppdagades i Hygga

Panostajas vinst för augusti-oktober var lägre än våra förväntningar. Den största besvikelsen kom dock från moderbolagets nettokassa, vars betydande minskning förklarades av nedskrivningen av koncerninterna lån till Hygga. Vi hade tidigare lyft fram detta som en möjlig risk, men omfattningen av de realiserade förlusterna överraskade oss.

Panostaja
Apetit: Small dent in Food Solutions’ earnings development
Research12/15/2025, 8:38 AM by
Pauli Lohi

Apetit: Small dent in Food Solutions’ earnings development

The company cited delays in harvest season production as the reason for the profit warning.

Apetit
Tokmanni omfattande analys: En tid av stora förändringar
Extensive research12/15/2025, 5:05 AM by
Arttu Heikura

Tokmanni omfattande analys: En tid av stora förändringar

Tokmannis investerarberättelse är i en övergångsfas, då företaget gör ändringar i Dollarstores affärsmodell och strävar efter att stärka sin inhemska tillväxt genom SPAR-samarbetet.

Tokmanni Group
Remedy: Release of Control Resonant marks turning point in investment story
Research12/15/2025, 9:58 AM by
Atte Riikola

Remedy: Release of Control Resonant marks turning point in investment story

The upcoming Control sequel is a critical release for Remedy's investment case, and we are confident in its success.

Remedy Entertainment
Honkarakenne: Ytterligare stöd för nästa års resultatvändning
Research12/15/2025, 4:30 AM by
Atte Jortikka

Honkarakenne: Ytterligare stöd för nästa års resultatvändning

Att leveranser av export med högre marginal flyttas till nästa år, samt företagets effektiviseringsåtgärder, stöder vårt estimat om en resultatvändning nästa år.

Honkarakenne
GreenMobility (One-pager): Fourth guidance upgrade highlights continued operational momentum
Research12/12/2025, 12:45 PM by
Michael Friis, Victor Skriver

GreenMobility (One-pager): Fourth guidance upgrade highlights continued operational momentum

Yesterday, GreenMobility raised its 2025 guidance for both revenue and EBITDA for the fourth time this year, driven by stronger-than-expected revenue development. We have updated our One-pager analysis with the upgraded 2025 guidance and latest price movements.

GreenMobility
Inderes Group - Strong CMD season backs clear beat in November - SEB
Research12/12/2025, 12:03 PM

Inderes Group - Strong CMD season backs clear beat in November - SEB

Inderes delivered solid monthly sales in November with sales increasing by 15% y/y. The strong growth owes to improved CMD activity. The sales beat our estimate by EUR 0.2m, which was the case also in October. Consequently, after two months of reporting in Q4 the sales run-rate is some EUR 0.4m above our current projection. Our positive read-x is also supported by the fact that Inderes has managed to win CMDs also in Sweden.

Inderes
Fondia extensive report: Number one in continuous legal services
Extensive research12/15/2025, 9:15 AM by
Juha Kinnunen

Fondia extensive report: Number one in continuous legal services

Fondia is undergoing major transitions, and its earnings turnaround  is only just beginning. However, unlike in the past, strong measures have been taken, and success in strategic projects would lead to a significant improvement in results. This also supports confidence in a change in the outcome. Despite its challenges, Fondia is the market leader in continuous legal services in Finland, in view of which its valuation is extremely low.

Fondia
Ilkka omfattande analys: Lönsam tillväxt med förnyad struktur
Extensive research12/12/2025, 6:00 AM by
Roni Peuranheimo

Ilkka omfattande analys: Lönsam tillväxt med förnyad struktur

Efter avyttringen av medieverksamheten fokuserar Ilkka på lönsam tillväxt inom marknadsföring, teknik och datatjänster, men den största värdedrivaren för aktien är fortfarande företagets ägande i Alma Media.

Ilkka
Rapala: Riktlinjerna för de kommande åren börjar ta form
Research12/12/2025, 5:30 AM by
Thomas Westerholm

Rapala: Riktlinjerna för de kommande åren börjar ta form

Vi har beaktat Rapalas balansräkningsrefinansiering och gjort smärre justeringar i våra operationella estimat.

Rapala VMC
Scanfil: Accelerating earnings growth starts to attract
Research12/12/2025, 7:58 AM by
Antti Viljakainen

Scanfil: Accelerating earnings growth starts to attract

However, with the valuation decrease due to the recent around 10% price drop (2026e: P/E 12x), we feel the expected return has improved and risen slightly above the required return. In our view, Scanfil also offers an attractive investment story of profitable growth in the longer term.

Scanfil
Sanoma: On the verge of accelerating earnings growth
Research12/12/2025, 11:16 AM by
Petri Gostowski

Sanoma: On the verge of accelerating earnings growth

We have reviewed our estimates following Sanoma's Capital Markets Day and updated financial targets.

Sanoma
Martela: Cyklisk återhämtning kom aldrig igång
Research12/11/2025, 7:45 AM by
Thomas Westerholm

Martela: Cyklisk återhämtning kom aldrig igång

Martela utfärdade en kraftig negativ vinstvarning, vilket har lett till att vi har sänkt våra estimat.

Martela
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.